🔗 Share this article

Chancellor Reeves has stated she is preparing "focused steps to address cost of living issues" in the upcoming Budget.

Speaking to media outlets, she stated that curbing price rises is a shared responsibility of both the government and the central bank.

The United Kingdom's inflation rate is expected to be the highest among the G7 industrialized countries this year and the following year.

Potential Utility Bill Measures

It is understood the government could take action to reduce utility costs, for instance by slashing the current 5% rate of value-added tax applied on energy.

An additional possibility is to cut some of the policy costs presently included in household expenses.

Fiscal Constraints and Analyst Predictions

The administration will obtain the latest draft from the official forecaster, the OBR, on the start of the week, which will show how much room there is for such actions.

The consensus from the majority of experts is that the Chancellor will have to declare higher taxes or spending cuts in order to fulfill her voluntary fiscal targets.

Previously on Thursday, calculations suggested there was a £22bn shortfall for the chancellor to fill, which is at the lower end of expectations.

"It is a shared task between the central bank and the administration to continue tackling some of the drivers of inflation," the Chancellor told the BBC in the US capital, at the conferences of the IMF and World Bank.

Tax Commitments and International Concerns

While a great deal of the focus has been on expected tax increases, the Treasury chief said the most recent information from the OBR had not altered her commitment to manifesto promises not to raise tax levels on earnings tax, VAT or social security contributions.

She attributed an "uncertain world" with rising geopolitical and trade tensions for the fiscal revenue measures, likely to be focused on those "with the broadest shoulders."

International Economic Tensions

Commenting on concerns about the United Kingdom's economic relations with the Asian nation she said: "The UK's national security always come first."

Last week's announcement by China to strengthen trade restrictions on rare earths and other materials that are essential for advanced tech manufacturing led US President Donald Trump to propose an further 100% tariff on imports from the Asian country, increasing the risk of an all-out trade war between the two economic giants.

The US Treasury Secretary described the Chinese action "economic coercion" and "a international production control attempt."

Asked about considering the American proposal to join its dispute with the Asian nation, the Chancellor said she was "deeply worried" by Chinese actions and encouraged the Chinese government "not to put up barriers and restrict access."

She said the action was "bad for the international commerce and causes additional obstacles."

"I believe there are sectors where we should challenge Chinese policies, but there are also valuable opportunities to sell into Chinese markets, including financial services and other areas of the economy. We've got to achieve that equilibrium appropriate."

The chancellor also stated she was working with G7 counterparts "on our own essential resources plan, so that we are less reliant."

NHS Drug Costs and Investment

Reeves also recognized that the price the NHS pays for drugs could rise as a consequence of ongoing talks with the Trump administration and its drugs companies, in return for reduced taxes and funding.

A number of the biggest global pharmaceutical manufacturers have said recently that they are either halting or abandoning operations in the United Kingdom, with some attributing the low prices they are receiving.

Recently, the Science Minister said the price the health service pays for drugs would need to go up to prevent firms and drug research funding departing from the UK.

The Chancellor informed the BBC: "It has been observed because of the cost structure, that clinical trials, new drugs have not been available in the UK in the manner that they are in other European countries."

"We want to guarantee that patients getting treatment from the NHS are able to access the top essential medicines in the globe. And so we are looking at all of that, and... aiming to secure more investment into Britain."